Desmethylanethole trithione derivatives for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production
US11484529B2 · kind B2 · utility
1Cited by
0References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 7, 2018 |
| Grant date | Nov 1, 2022 |
| Priority date | — |
| Expiry date | Oct 15, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to desmethylanethole trithione (AOX) and derivatives thereof, especially derivatives of formula (I), for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin,
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.